Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group
- PMID: 26488767
- PMCID: PMC4712103
- DOI: 10.1002/ijc.29894
Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group
Abstract
Prostate cancer is a significant public health burden and a major cause of morbidity and mortality among men worldwide. Analyzing geographic patterns and temporal trends may help identify high-risk populations, suggest the degree of PSA testing, and provide clues to etiology. We used incidence data available from the International Agency for Research on Cancer (IARC) and certain cancer registries for 43 populations across five continents during a median period of 24 years. Trends in overall prostate cancer rates showed five distinct patterns ranging from generally monotonic increases to peaking of rates followed by declines, which coincide somewhat with changes in the prevalence of PSA testing. Trends in age-specific rates generally mirrored those in the overall rates, with several notable exceptions. For populations where overall rates increased rapidly and then peaked, exemplified in North America and Oceania, the highest incidence tended to be most pronounced and occurred during earlier calendar years among older men compared with younger ones. For populations with almost continual increases in overall rates, exemplified in Eastern Europe and Asia, peaks were evident among men aged ≥ 75 years in many instances. Rates for ages 45-54 years did not clearly stabilize or decline in the majority of studied populations. Global geographic variation remained substantial for both overall and age-specific incidence rates regardless of levels of PSA testing, with the lowest rates consistently in Asia. Explanations for the persistent geographic differences and the continuing increases of especially early-onset prostate cancer remain unclear.
Keywords: age-specific; incidence; international; prostatic neoplasms; trends.
© 2015 UICC.
Figures




Similar articles
-
Prostate cancer incidence and mortality trends among elderly and adult Europeans.Crit Rev Oncol Hematol. 2000 Aug;35(2):133-44. doi: 10.1016/s1040-8428(99)00067-0. Crit Rev Oncol Hematol. 2000. PMID: 10936470
-
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.Eur Urol. 2016 Nov;70(5):862-874. doi: 10.1016/j.eururo.2016.05.043. Epub 2016 Jun 8. Eur Urol. 2016. PMID: 27289567
-
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.Eur Urol. 2020 Jan;77(1):38-52. doi: 10.1016/j.eururo.2019.08.005. Epub 2019 Sep 5. Eur Urol. 2020. PMID: 31493960 Review.
-
International trends in lung cancer incidence from 1973 to 2007.Cancer Med. 2018 Apr;7(4):1479-1489. doi: 10.1002/cam4.1359. Epub 2018 Mar 14. Cancer Med. 2018. PMID: 29542259 Free PMC article.
-
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.BJU Int. 2002 Jul;90(2):162-73. doi: 10.1046/j.1464-410x.2002.2822.x. BJU Int. 2002. PMID: 12081758 Review.
Cited by
-
The influence of age on prostate cancer screening index.J Clin Lab Anal. 2022 Jan;36(1):e24098. doi: 10.1002/jcla.24098. Epub 2021 Nov 24. J Clin Lab Anal. 2022. PMID: 34816496 Free PMC article.
-
Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients.Aging (Albany NY). 2021 Jun 18;13(12):16316-16340. doi: 10.18632/aging.203158. Epub 2021 Jun 18. Aging (Albany NY). 2021. PMID: 34148031 Free PMC article.
-
Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?Biomed Res Int. 2017;2017:1438027. doi: 10.1155/2017/1438027. Epub 2017 Feb 7. Biomed Res Int. 2017. PMID: 28265568 Free PMC article. Clinical Trial.
-
Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.Cancer Immunol Immunother. 2018 Mar;67(3):413-422. doi: 10.1007/s00262-017-2097-5. Epub 2017 Nov 29. Cancer Immunol Immunother. 2018. PMID: 29188305 Free PMC article.
-
The effect of prostate motion during hypofractionated radiotherapy can be reduced by using flattening filter free beams.Phys Imaging Radiat Oncol. 2018 May 25;6:66-70. doi: 10.1016/j.phro.2018.05.001. eCollection 2018 Apr. Phys Imaging Radiat Oncol. 2018. PMID: 33458391 Free PMC article.
References
-
- Ferlay JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11[Internet] Lyon, France: International Agency for Research on Cancer; 2013.
-
- Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in black and white men: An analysis of Medicare claims from 1991–1998. Urology. 2002;59:251–255. - PubMed
-
- Potosky AL, Kessier L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased rse of transurethral resection. Journal of the National Cancer Institute. 1990;82:1624–1628. - PubMed
-
- Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007;99:1881–1887. - PubMed
-
- Neppl-Huber C, Zappa M, Coebergh JW, Rapiti E, Rachtan J, Holleczek B, Rosso S, Aareleid T, Brenner H, Gondos A. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol. 2012;23:1325–1334. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous